PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “AMERICAN SOCIETY OF CLINICAL PATHOLOGISTS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1994

Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists.

The American Society of Clinical Pathologists surveyed 395 members who represented the spectrum of anatomic pathology practice among the membership. The results of how respondents fix, section, process, and report radical prostatectomy specimens, transurethral prostatectomy specimens, and needle biopsy specimens is presented, with a commentary based on the current medical literature.

Biopsy, Needle↗
PubMed1995

Surgical pathology examination of lymph nodes. Practice survey by American Society of Clinical Pathologists.

The American Society of Clinical Pathologists surveyed 363 pathologists to determine practices used in processing and reporting lymph node specimens submitted for surgical pathology examination. This topic is of interest because lymph nodes are some of the more common organs biopsied for diagnostic purposes and the constant change in and diversity of classification systems in the past 30 years. The definition of newly recognized entities and the use of sophisticated diagnostic tools also have made it difficult for there to be a solid consensus of pathologists in diagnosing lymphoproliferative disorders for correlation with clinical behavior and response to therapy. The survey, conducted in November 1992, contained 79 questions. Participants were selected to represent a variety of practice settings and 179 (49%) responses were received.

Biopsy, Needle↗
PubMed1999

Current practices in clinical flow cytometry. A practice survey by the American Society of Clinical Pathologists.

The American Society of Clinical Pathologists surveyed 136 laboratories actively engaged in performing clinical flow cytometric testing to determine the demographics of these laboratories, the credentials of the personnel involved with testing, the volume and types of tests performed, and how data are analyzed and interpreted. These results are reported with commentary based on previous surveys and recommended practice guidelines.

Data Collection↗
PubMed1998

The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article.

The major conclusions of this position article are as follows: (1) In the absence of a history of a bleeding disorder, the bleeding time is not a useful predictor of the risk of hemorrhage associated with surgical procedures. (2) A normal bleeding time does not exclude the possibility of excessive hemorrhage associated with invasive procedures. (3) The bleeding time cannot be used to reliably identify patients who may have recently ingested aspirin or nonsteroidal anti-inflammatory agents or those who have a platelet defect attributable to these drugs. The best preoperative screen to predict bleeding continues to be a carefully conducted clinical history that includes family and previous dental, obstetric, surgical, traumatic injury, transfusion, and drug histories. A history suggesting a possible bleeding disorder may require further evaluation; such an evaluation may include performance of the bleeding time test, as well as a determination of the platelet count, the prothrombin time, and the activated partial thromboplastin time. In the absence of a history of excessive bleeding, the bleeding time fails as a screening test and is, therefore, not indicated as a routine preoperative test.

Anti-Inflammatory Agents, Non-Steroidal↗
PubMed1999

Proposed method for evaluating secondary screening (rescreening) instruments for gynecologic cytology. Intersociety Working Group for Cytology Technologies.

This method for evaluating secondary screening (rescreening) instruments for gynecologic cytology was approved by the governing boards of 6 societies represented in the Intersociety Working Group for Cytology Technologies: American Society for Cytotechnology, American Society of Clinical Pathologists, American Society of Cytopathology, College of American Pathologists, International Academy of Cytology, and Papanicolaou Society of Cytopathology. The proposed method, as written, reflects the current status of technologies in early 1998.

Cytological Techniques↗
PubMedDate not supplied

Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.

The recommendations and activities of the American Society of Clinical Pathologists (ASCP) pertaining to quality assurance in cytopathology are reviewed. To assure the early detection of cervical cancer, the ASCP recommends that all women who are, or have been, sexually active should have an annual Papanicolaou smear examination, the reasons for which are discussed. To assure the optimal quality in the evaluation of these smears, the ASCP recommends that the screening should be performed (1) in an accredited laboratory by certified cytotechnologists, (2) for whom realistic workloads have been established, (3) under the supervision of a pathologist adequately trained in cytology, (4) who will maintain an ongoing quality assurance program. In addition, (5) Papanicolaou smear evaluations should be available to all patients at a reasonable cost and (6) the financial incentives for the performance of low-quality screening should be eliminated. The society's quality assurance activities discussed include the Check Sample program, self-assessment examinations, meetings and publications; planned additions to this arena include a challenge exam and proficiency survey mechanisms.

Cytodiagnosis↗
PubMed1996

Prevention of transfusion-associated cytomegalovirus infection. Practice parameter. American Society of Clinical Pathologists.

This practice guideline represents the opinions and recommendations of the author(s), the American Society of Clinical Pathologists (ASCP) Practice Parameters Committee and the ASCP Board of Directors regarding the appropriate strategies for each clinical condition or laboratory test discussed in this guideline. This guideline is designed primarily as an educational resource for physicians in the provision of quality medical services. Adherence to this guideline is completely voluntary and does not necessarily assure a successful medical treatment or result. This practice guideline should not be considered inclusive of all proper procedures and tests or exclusive of other procedures or tests that are reasonably directed to obtaining the same results. The physician should apply his or her own professional judgment to the unique clinical circumstances presented by the particular procedure or test. Physicians are encouraged to document the reasons for whatever procedure or test they use (whether or not in conformance with this guideline). Physicians should also take care to consider other medical and scientific advances that are available after the date of adoption of this guideline. This practice guideline was developed exclusively for the purposes set forth above and not for use in connection with matters involving reimbursement, credentialing, or utilization review.

Adult↗
PubMed1996

American Society of Clinical Pathologists--Resident Physician Section. Results of autopsy survey (Winter 1994-1995)

The recent debate on autopsy and the role of this unique doctor-patient relationship in the modern medical profession prompted the Resident Physician Section of the American Society of Clinical Pathologists to conduct a survey on postmortem practice as it relates to pathology residents. A total of 102 of 176 (58%) Resident Physician Section (RPS) liaisons from pathology residency programs in the United States, Canada, and Puerto Rico responded to a survey that consisted of 30 questions. The findings of the survey confirm the decrease in autopsy numbers, highlighting the problem of providing sufficient autopsy training to pathology residents. Interestingly, the majority of programs showed a striking similarity with regard to basic autopsy protocol procedures. Liaisons identified incorporation of clinical pathology, basic science, and clinicopathologic interaction as areas of weakness. In the final analysis, the majority of liaisons had a favorable opinion of their autopsy experience.

Autopsy↗
PubMed1998

Proposed guidelines for primary screening instruments for gynecologic cytology. Intersociety Working Group for Cytology Technologies.

These guidelines were approved by the governing boards of the following six societies represented in the Intersociety Working Group for Cytology Technologies: American Society for Cytotechnology (ASCT), American Society of Clinical Pathologists (ASCP), American Society of Cytopathology (ASC), College of American Pathologists (CAP), International Academy of Cytology (IAC), and Papanicolaou Society of Cytopathology (PSC). The proposed guidelines as written reflect the current status of technologies in early 1997. These guidelines may evolve over time as newer technologies are developed.

Cervix Uteri↗
PubMed1997

Critical values: ASCP practice parameter. American Society of Clinical Pathologists.

Appropriate use of critical values improves patient outcome by ensuring that physicians are promptly notified of immediate life-threatening conditions. Conversely, overuse squanders resources and actually may impair patient outcome. A generic critical values list derived from interlaboratory surveys is an excellent starting point, but every laboratory must customize its list to meet the needs of the organization that it serves. Category-specific and once-per-period critical values can limit superfluous reporting, but they make the critical values list more complicated. Strict semantic interpretation of critical limits is appropriate. The best ways to report critical values are by telephone and by alphanumeric pager. When required, repeat analysis should precede critical value reporting. Laboratories should avoid reporting invalid results (due to poor specimen integrity, for example) as critical values. An institutional committee initially should approve, and periodically should review and revise, the critical values policy.

Clinical Laboratory Information Systems↗